News
Humana faces real challenges like falling Medicare star ratings, shrinking margins, and tough competition. Click here to read ...
Humana could face $1 billion to $3 billion in losses next year, with the star ratings drop in its Medicare Advantage program.
Analysts have recently evaluated Humana and provided 12-month price targets. The average target is $280.75, accompanied by a ...
2d
Zacks.com on MSNUnitedHealthcare Pressure Builds: Trouble Ahead for UNH's Q2 Earnings?Plunging profits from its UnitedHealthcare unit are expected to have affected UNH’s second-quarter results. Recent challenges ...
Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.3% in the morning session after the stock gained ...
9d
InvestorsHub on MSNHumana stock falls to 52-week low of $212.33 amid sector challengesHumana Inc. (NYSE:HUM) saw its share price drop to a 52-week low of $212.33, reflecting a steep 42.3% decline over the past ...
Humana (NYSE:HUM) recently launched the inaugural Humana Cognitive Games™ to promote brain health among older adults, coinciding with their tenth year sponsoring the National Senior Games. This ...
We should also highlight that HUM has a P/B ratio of 1.64. The P/B is a method of comparing a stock's market value to its book value, which is defined as total assets minus total liabilities.
Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and ...
16d
Barchart on MSNHere's What to Expect From Humana's Next Earnings ReportValued at a market cap of $28 billion, Humana Inc. (HUM) is a leading U.S. health care plan provider offering medical and specialty insurance products. Operating through its Insurance and CenterWell ...
This summary covers significant health news including FDA advisers rejecting Otsuka's PTSD treatment, Getinge exceeding ...
StockStory.org on MSN5d
Why AMN Healthcare Services (AMN) Stock Is Trading Up TodayShares of healthcare staffing company AMN Healthcare Services (NYSE:AMN) jumped 6% in the afternoon session after Truist Securities reiterated its 'Buy' rating on the company. The Wall Street firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results